Oral sildenafil for persistent pulmonary hypertension early after congenital cardiac surgery in children

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 1, 2010, Pages 71-77

  Nemoto, Shintaro ^a   Sasaki, Tomoyasu ^a   Ozawa, Hideki ^a   Katsumata, Takahiro ^a   Kishi, Kanta ^a   Okumura, Kenichi ^a   Mori, Yasuhiko ^a   Umegaki, Osamu ^a  

^a OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

Cardiac surgery; Congenital cardiac anomaly; Pulmonary hypertension; Sildenafil

Indexed keywords

BOSENTAN; NITROUS OXIDE; SILDENAFIL;

ARTICLE; CHILD; CONGENITAL HEART DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HEMODYNAMIC MONITORING; HUMAN; INFANT; LUNG ARTERY PRESSURE; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; OPEN HEART SURGERY; OXYGEN SATURATION; PERSISTENT PULMONARY HYPERTENSION; POSTOPERATIVE CARE; PRIORITY JOURNAL; VENTRICULOATRIAL SHUNT;

ADMINISTRATION, ORAL; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; OXYGEN CONSUMPTION; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PULMONARY CIRCULATION; PURINES; SULFONES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77953324769     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.01.045     Document Type: Article

References (24)

1. Hopkins R.A., Bull C., Haworth S.G., de Leval M.R., and Stark J. Pulmonary hypertension crisis following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 5 (1991) 628-634
2. Schulze-Neick I., Li J., Penny D.J., and Redington A.N. Pulmonary vascular resistance after cardiopulmonary bypass in infants: effect on postoperative recovery. J Thorac Cardiovasc Surg 121 (2001) 1033-1039
3. Morita K., Ihnkem K., Buckberg G.D., Sherman M.P., and Ignarro L.J. Pulmonary vasoconstriction due to impaired nitric oxide production after cardiopulmonary bypass. Ann Thorac Surg 61 (1996) 1775-1780
4. Glavind-Kristensen M., Brix-Kristensen V., Toennesen E., Ravn H.B., Forman A., Sorensen K., and Hjordal V.E. Pulmonary endothelial dysfunction after cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand 46 (2002) 853-859
5. Miller O.I., Celermajer D.S., Deanfield J.E., and Macrae D.J. Very-low-dose nitric oxide; a selective pulmonary vasodilator after operation for congenital heart disease. J Thorac Cardiovasc Surg 108 (1994) 487-494
6. Curran R.D., Mavroudis C., Backer C.L., Sautel M., Zales V.R., and Wessel D.L. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg 60 (1995) 1765-1771
7. Miller O.I., Tsang S.F., Keech A., and Clermajer D.S. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346 (1995) 51-52
8. Atz A.M., Adatia I., and Wessel D.L. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 62 (1996) 1759-1764
9. Stocker C., Penny D.J., Brizard C.P., Cochrane A.D., Soto R., and Shekerdemian L.S. Intravenous sildenafil and inhaled nitric oxide: a randomized trial in infants after cardiac surgery. Intensive Care Med 29 (2003) 1996-2003
10. Leuchte H.H., Schwaiblmair M., Baumgartner R.A., Neurohr C.F., Kolbe T., and Behr J. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Chest 125 (2004) 580-586
11. Reffelmann T., and Kloner R.A. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation 108 (2003) 239-244
12. Schulze-Neick I., Hartenstein P., Li J., Stiller B., Nagdyman N., Hübler M., Butrous G., Petros A., Lange P., and Redington A.N. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 108 Suppl. II (2003) II-167-II-173
13. Atz A.M., Lefler A.K., Fairbrother D.L., Uber W.E., and Bradley S.M. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crisis. J Thorac Cardiovasc Surg 124 (2002) 628-629
14. Atz A.M., and Wessel D.L. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91 (1999) 307-310
15. Shekerdemian L.S., Ravn H.B., and Penny D.J. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165 (2002) 1098-1102
16. Namachivayam P.N., Theiler J., Butt W.W., Cooper S.M., Penny D.J., and Shekerdemian L.S. Sildenafil prevents pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med 174 (2006) 1042-1047
17. Lee J.E., Hillier S.C., and Knoderer C.A. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease. J Intensive Care Med 23 (2008) 329-334
18. Raja S.G., Danton M.D., MacArthur K.J., and Pollock J.C. Effects of escalating doses of sildenafil on hemodynamic and gas exchange in children with pulmonary hypertension and congenital cardiac defects. J Cardiothorac Vasc Anesth 2 (2007) 203-207
19. Nemoto S., Umehara E., Ikeda T., Itonaga T., and Komeda M. Oral sildenafil ameliorates impaired pulmonary circulation early after bidirectional cavopulmonary shunt. Ann Thorac Surg 83 (2007) e11-e13
20. Black S.M., Heidersbach R.S., McMullan D.M., Bekker J.M., Johengen M.J., and Fineman J.R. Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am J Physiol 277 (1999) H1849-H1856
21. Pearl J.M., Nelson D.P., Raake J.L., Manning P.B., Schwartz S.M., Koons L., Shanley T.P., Wong H.R., and Duffy J.Y. Inhaled nitric oxide increases endothelin-1 levels; a potential cause of rebound pulmonary hypertension. Crit Care Med 30 (2002) 89-93
22. Yamaki S., Horiuchi T., and Sekino Y. Quantitative analysis of pulmonary vascular disease in simple cardiac anomalies with the Down syndrome. Am J Cardiol 51 (1983) 1502-1506
23. Beghetti M., Black S.M., and Fineman J.R. Endothelin-1 in congenital heart disease. Pediatr Res 57 (2005) 16R-20R
24. Kageyama K., Hashimoto S., Nakajima Y., Shime N., and Hashimoto S. The changes of plasma endothelin-1 levels before and after surgery with or without Down syndrome. Pediatr Anesth 17 (2007) 1071-1077